INDAPTUS THERAPEUTICS

1.0400

26-十一月-24 16:45:00

15 分钟延时

股票

+0.0100

+0.97%

今日范围

1.0101 - 1.0600

ISIN

N/A

来源

NASDAQ

Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement

22 11月 2024 08:36:14 条件 Nasdaq GlobeNewswire
Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

12 11月 2024 08:00:01 条件 Nasdaq GlobeNewswire
Indaptus Therapeutics’ Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in Immunology

11 11月 2024 08:00:00 条件 Nasdaq GlobeNewswire
Indaptus Therapeutics Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting

07 11月 2024 08:00:01 条件 Nasdaq GlobeNewswire
Indaptus Therapeutics to Present at Two Upcoming Investor Conferences

23 10月 2024 08:00:01 条件 Nasdaq GlobeNewswire
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations

22 10月 2024 08:00:01 条件 Nasdaq GlobeNewswire
Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data

15 10月 2024 08:00:00 条件 Nasdaq GlobeNewswire

<<
<
1
>

我同意 NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie 政策, 隐私政策 and 条款与条件.